- Home
- ALGM vs PTGX Comparison
ALGM vs PTGX Comparison
Compare ALGM & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGM
- PTGX
- Stock Information
- Founded
- ALGM 1990
- PTGX 2006
- Country
- ALGM United States
- PTGX United States
- Employees
- ALGM N/A
- PTGX N/A
- Industry
- ALGM Semiconductors
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ALGM Technology
- PTGX Health Care
- Exchange
- ALGM Nasdaq
- PTGX Nasdaq
- Market Cap
- ALGM 3.5B
- PTGX 2.9B
- IPO Year
- ALGM 2020
- PTGX 2016
- Fundamental
- Price
- ALGM $30.96
- PTGX $53.34
- Analyst Decision
- ALGM Strong Buy
- PTGX Strong Buy
- Analyst Count
- ALGM 8
- PTGX 9
- Target Price
- ALGM $29.13
- PTGX $67.11
- AVG Volume (30 Days)
- ALGM 1.7M
- PTGX 998.2K
- Earning Date
- ALGM 07-31-2025
- PTGX 08-05-2025
- Dividend Yield
- ALGM N/A
- PTGX N/A
- EPS Growth
- ALGM N/A
- PTGX N/A
- EPS
- ALGM N/A
- PTGX 0.86
- Revenue
- ALGM $725,006,000.00
- PTGX $207,801,000.00
- Revenue This Year
- ALGM $18.36
- PTGX N/A
- Revenue Next Year
- ALGM $18.98
- PTGX $47.15
- P/E Ratio
- ALGM N/A
- PTGX $61.84
- Revenue Growth
- ALGM N/A
- PTGX N/A
- 52 Week Low
- ALGM $16.38
- PTGX $30.67
- 52 Week High
- ALGM $33.26
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- ALGM 67.27
- PTGX 58.33
- Support Level
- ALGM $28.48
- PTGX $54.48
- Resistance Level
- ALGM $31.66
- PTGX $57.18
- Average True Range (ATR)
- ALGM 1.05
- PTGX 2.04
- MACD
- ALGM 0.10
- PTGX -0.09
- Stochastic Oscillator
- ALGM 89.18
- PTGX 57.13
About ALGM Allegro MicroSystems Inc.
Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.